A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE

NCT03312907 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

292

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Belimumab
DRUG: Rituximab
DRUG: Rituximab-placebo
DRUG: Standard therapy (Including Immunosuppressants)
DRUG: Standard therapy (Excluding Immunosuppressants)
DRUG: Steroid Taper

Sponsor

GlaxoSmithKline